Peapod Lane Capital LLC Invests $991,000 in Seer, Inc. (NASDAQ:SEER)

Peapod Lane Capital LLC bought a new stake in Seer, Inc. (NASDAQ:SEERFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 428,904 shares of the company’s stock, valued at approximately $991,000. Peapod Lane Capital LLC owned approximately 0.73% of Seer at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. AQR Capital Management LLC acquired a new position in shares of Seer during the 2nd quarter worth about $30,000. Quadrature Capital Ltd raised its holdings in Seer by 301.7% during the third quarter. Quadrature Capital Ltd now owns 57,088 shares of the company’s stock worth $112,000 after acquiring an additional 42,875 shares in the last quarter. XTX Topco Ltd bought a new stake in Seer during the third quarter worth about $123,000. Barclays PLC boosted its position in Seer by 34.1% during the third quarter. Barclays PLC now owns 64,426 shares of the company’s stock valued at $127,000 after purchasing an additional 16,382 shares during the last quarter. Finally, Cubist Systematic Strategies LLC bought a new position in Seer in the second quarter valued at approximately $133,000. Institutional investors own 75.20% of the company’s stock.

Seer Trading Down 0.4 %

Shares of Seer stock opened at $2.25 on Thursday. Seer, Inc. has a 12-month low of $1.51 and a 12-month high of $2.63. The business’s 50 day moving average is $2.35 and its 200-day moving average is $2.08.

Seer Company Profile

(Free Report)

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

See Also

Institutional Ownership by Quarter for Seer (NASDAQ:SEER)

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.